Stromal Lkb 1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11 – JAK / STAT 3 pathway

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence Analysis

  2020cited by this paper
• JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms.

  2017cited by this paper
• Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

  2017cited by this paper
• Liver kinase B1 inhibits the expression of inflammation-related genes postcontraction in skeletal muscle.

  2016cited by this paper
• STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.

  2016cited by this paper
• Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases.

  2016cited by this paper
• Morphologic characterization of hamartomatous gastrointestinal polyps in Cowden syndrome, Peutz-Jeghers syndrome, and juvenile polyposis syndrome.

  2016cited by this paper
• Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.

  2016cited by this paper
• IL-11 signaling as a therapeutic target for cancer.

  2015cited by this paper
• Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer.

  2014cited by this paper
• Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor κB (NF-κB) Activation in Macrophages*

  2014cited by this paper
• Molecular Pathways: IL11 as a Tumor-Promoting Cytokine—Translational Implications for Cancers

  2014cited by this paper
• The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy.

  2014cited by this paper
• The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in mice

  2014cited by this paper
• Peutz-Jeghers syndrome: a critical look at colonic Peutz-Jeghers polyps

  2013cited by this paper
• Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.

  2013cited by this paper
• Identification of molecular alterations in gastrointestinal carcinomas and dysplastic hamartomas in Peutz-Jeghers syndrome.

  2013cited by this paper
• Interleukin-6 and interleukin-11: same same but different

  2013cited by this paper
• Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression

  2013cited by this paper
• Establishment of Gastrointestinal Epithelial Organoids

  2013cited by this paper
• Stromal Liver Kinase B1 [STK11] Signaling Loss Induces Oviductal Adenomas and Endometrial Cancer by Activating Mammalian Target of Rapamycin Complex 1

  2012cited by this paper
• Understanding the role of stromal fibroblasts in cancer progression

  2012cited by this paper
• Stat3: Linking inflammation to (gastrointestinal) tumourigenesis

  2012cited by this paper
• Elevation of WNT5A expression in polyp formation in Lkb1+/− mice and Peutz–Jeghers syndrome

  2011influential reference
• The tumor suppressor kinase LKB1: lessons from mouse models.

  2011cited by this paper
• Lkb1 and Pten Synergise to Suppress mTOR-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in the Mouse Bladder

  2011cited by this paper
• Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

  2011cited by this paper
• The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism

  2011cited by this paper
• Molecular signatures database (MSigDB) 3.0

  2011cited by this paper
• SMAD4 Immunohistochemistry Reflects Genetic Status in Juvenile Polyposis Syndrome

  2010cited by this paper
• Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells.

  2010cited by this paper
• Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.

  2010cited by this paper
• A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

  2009cited by this paper
• mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome

  2009cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• The LKB1–AMPK pathway: metabolism and growth control in tumour suppression

  2009cited by this paper
• Oral rapamycin reduces tumour burden and vascularization in Lkb1+/− mice

  2009cited by this paper
• STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

  2009cited by this paper
• Breast cancer by proxy: can the microenvironment be both the cause and consequence?

  2009cited by this paper
• The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.

  2009cited by this paper
• Lkb1 is required for TGFβ-mediated myofibroblast differentiation

  2008influential reference
• Mesenchymal–epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas

  2008cited by this paper
• Direct evidence for epithelial-mesenchymal transitions in breast cancer.

  2008cited by this paper
• Smad4 haploinsufficiency: a matter of dosage

  2008cited by this paper
• LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis

  2008influential reference
• STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

  2008influential reference
• PTEN-deficient intestinal stem cells initiate intestinal polyposis

  2007cited by this paper
• A global double‐fluorescent Cre reporter mouse

  2007cited by this paper
• Impaired gastric gland differentiation in Peutz-Jeghers syndrome.

  2007influential reference
• The LKB1 tumor suppressor kinase in human disease.

  2007cited by this paper
• Peutz–Jeghers syndrome polyps are polyclonal with expanded progenitor cell compartment

  2007cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• LKB1 modulates lung cancer differentiation and metastasis

  2007cited by this paper
• Identification of fibroblast heterogeneity in the tumor microenvironment

  2006cited by this paper
• Fibroblasts in cancer

  2006cited by this paper
• Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.

  2005influential reference
• LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1

  2004cited by this paper
• Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.

  2004cited by this paper
• Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.

  2004cited by this paper
• Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth

  2003cited by this paper
• The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity

  2003cited by this paper
• Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps.

  2002cited by this paper
• Induction of cyclooxygenase-2 in a mouse model of Peutz–Jeghers polyposis

  2002influential reference
• Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice

  2002cited by this paper
• Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation

  2002cited by this paper
• Vascular Abnormalities and Deregulation of VEGF in Lkb1-Deficient Mice

  2001cited by this paper
• Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

  2001cited by this paper
• Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium.

  2000cited by this paper
• Generalized lacZ expression with the ROSA26 Cre reporter strain

  1999cited by this paper
• Br Ief Definitive Repor T

  year unknowncited by this paper

• Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients

  2023cites this paper
• IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR in hepatocytes, the stroma and cancer cells

  2022cites this paper
• Embryonic Kidney Development, Stem Cells and the Origin of Wilms Tumor

  2021cites this paper
• Oncogenic Ras cooperates with knockdown of the tumor suppressor Lkb1 by RNAi to override organ size limits in Drosophila wing tissue

  2020cites this paper
• STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer

  2019cites this paper